Latest news with #WCG
Yahoo
30-05-2025
- Business
- Yahoo
WCG launches integrated solution to enhance clinical trial process
WCG has launched the WCG Study Accelerator, an integrated solution designed to optimise the clinical trial process and enhance outcomes for institutions and sponsors worldwide. The solution focuses on expediting the execution of trials by aligning site choices, ethical reviews, and subject recruitment and retention into a unified strategy. It uses operational intelligence and real-time data to reduce risks, prevent engagement with underperforming sites, and shorten trial timelines by up to 20%. This approach allows sponsors to make informed site selections and improve enrolment efficiency. WCG chief operations officer Mark McDonald said: 'Study Accelerator not only provides a structured framework for executing trials efficiently, but also embeds flexibility and insights by streamlining site selection and participant enrolment and engagement processes. 'The solution combines advanced technology with hands-on support to ensure seamless implementation and execution, even for highly specialised or complex protocols. This truly enables smarter, faster trials.' According to the company, operational challenges, rather than scientific uncertainty, often cause delays in the trials. Issues such as disjointed planning, inconsistent execution of the site, and last-minute efforts to meet enrolment targets can lead to time wastage, increased expenses, and jeopardised outcomes. The solution is specifically engineered to solve these issues by integrating core operational functions into a performance-oriented framework that enhances decision-making, minimises obstacles, and enables trial advancement. WCG CEO Sam Srivastava said: 'With the launch of WCG Study Accelerator, we are addressing the well-known bottlenecks that have plagued clinical trials for years. Our solution exemplifies our commitment to innovation and customer-centricity by providing a model that propels trial execution forward with precision, speed, and integrity.' In March 2025, WCG launched ClinSphere Total Feasibility, a software-as-a-service (SaaS) platform aimed at refining site selection processes to aid sponsors and contract research organisations in making more decisions during clinical trial start-ups. "WCG launches integrated solution to enhance clinical trial process" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
IOL News
25-04-2025
- Automotive
- IOL News
Easter weekend sees significant crackdown on drunk driving in South Africa
More than 500 drivers were arrested for driving under the influence over the past Easter weekend. Image: WCG This past Easter weekend, law enforcement agencies across South Africa took a significant step towards road safety, arresting over 500 drivers for driving under the influence (DUI). As the nation approaches another two consecutive long weekends—which notably coincide with many people's payday—the urgent call for attention to the threat of drunk driving remains greater than ever. Despite the success of apprehending such a large number of unsafe drivers, the statistics starkly indicate that drunk driving continues to plague South African roads. Eugene Herbert, CEO of MasterDrive, urged policymakers and the public alike to prioritise the strategies that proved effective over the Easter weekend. 'Authorities should replicate measures taken over Easter weekend to keep these reckless drivers off the road. Additionally, as we face another two weekends where drivers are more likely to drive after drinking, the past weekend should serve as a warning that every organisation must take extremely seriously.' The ongoing campaign to eliminate drunk driving garnered fresh momentum during a recent roundtable discussion hosted by This collaborative effort saw thought leaders from various sectors, including the automotive industry, road safety organisations, and government agencies, come together to brainstorm sustainable solutions. 'Eliminating drunk driving is something MasterDrive prioritises. The organisation drives this message home through various activations that emphasise the danger of driving under the influence,' Herbert said. One such initiative, the 'Drunk Buster Goggles,' allows participants to experience the impairments associated with alcohol consumption while behind the wheel of a motorised scooter. This eye-opening experience leaves drivers with a stark understanding of how alcohol can affect vision and reaction times, emphasising the harsh realities of driving under the influence. This year marks a significant continuation of impactful Road Safety Programme, which has already shown considerable results in its first year. Notable achievements from the previous year included: 10,618 roadblocks conducted 9,894 arrests for drunk driving 275 offenders enrolled in the NICRO rehabilitation programme, with 95% of participants not reoffending. Memorandums of understanding established between Johannesburg Metro Police Department (JMPD), Road Traffic Management Corporation (RTMC), Tshwane, and eThekwini Metros. In 2024, is committed to enhancing these efforts. The organisation aims to engage policymakers, industry stakeholders, and the public in fostering lasting behavioural changes that will ultimately lead to a reduction in incidents of DUI. A key component of these efforts includes advocating for a 0% alcohol approach to road use. To support this mission, MasterDrive and other stakeholders will remain actively involved throughout the month, with several initiatives aimed at deterring drinking and driving. Their efforts will be bolstered by the JMPD, which will implement the Evidential Breath Alcohol Test (EBAT) for intoxicated drivers, a test that holds up in court. The RTMC encourages all road users to take action if they observe someone in an intoxicated state, while the Limpopo Road Safety Department calls on government and road agencies to share best practices and unify law enforcement efforts across provincial borders.
Business Standard
21-04-2025
- Entertainment
- Business Standard
WCG 2025 National Showdown India to Launch in Partnership with Upthrust Esports
VMPL Seoul [South Korea] / Mumbai (Maharashtra) [India], April 21: Global esports festival WCG (World Cyber Games) announced that its 2025 edition will feature a National Showdown in India this September, in partnership with India's premier esports company, Upthrust Esports. Following the success of WCG 2024, which introduced a creator-focused format for the first time, WCG 2025 will host National Showdowns in Korea, India, and the Philippines, culminating in a global festival in Indonesia this December. The Indian edition, titled WCG 2025 National Showdown India, will spotlight popular Indian gaming creators as they face off in Creator Rumble, a unique competition format that blends gaming skill with board-game-style randomness. Originally launched in 2024, Creator Rumble has rapidly grown into WCG's signature IP, offering a dynamic mix of competition, entertainment, and unpredictability. To bring this event to life, WCG's organizer Bigpicture Interactive has partnered with Upthrust Esports, one of India's leading event producers known for its work with gaming influencers and community-driven content. "India is one of the most dynamic and fast-growing gaming communities in the world," said Kyungjun Min, Director of Global IP Strategy Division at Bigpicture Interactive. "We're excited to collaborate with Upthrust Esports to deliver a creator-first experience that truly reflects India's passion for gaming and entertainment." "We are thrilled to partner with WCG to bring the world's premier gaming festival to India's doorstep. This Collaboration not only showcases the incredible talent & passion of our gaming community but also paves the way for a new era of opportunities - where Top Indian Creators will be participating & winning team will go against top global creators in the WCG Festival 2025 at the global stage. Together WCG & Upthrust are redefining what gaming & entertainment means in India & beyond." said Kartik Sabherwal, Founder & CEO, Upthrust Esports More details on the lineup of creators, competition format, and streaming platforms will be announced in the coming weeks. About WCG (World Cyber Games) Founded in 2000, WCG is one of the world's most iconic esports festivals. Today, it serves as a global platform that connects creators, gamers, and fans through interactive events and content. About Bigpicture Interactive Bigpicture Interactive is a South Korea-based media and esports company and the official organizer of WCG. The company specializes in creator-centered festival IPs that blend competitive gaming with audience engagement. About Upthrust Esports Upthrust Esports is a leading Indian esports event production company known for hosting large-scale tournaments and creator-based gaming shows. It is widely recognized for bridging brand engagement and gaming culture in India.
Yahoo
28-03-2025
- Business
- Yahoo
WCG launches SaaS solution to optimise trial site selection
WCG has launched the new software-as-a-service (SaaS) technology solution, ClinSphere Total Feasibility, to optimise clinical trial site selection. It is aimed at improving the decision-making processes for sponsors and contract research organisations (CROs) for clinical trial start-ups. This solution provides centralised access to trial data, helping to decrease redundancy and improve the feasibility and selection activities of the site. It uses WCG's extensive data and features 'pre-populated' surveys to minimise the workload at the site and expedite responses. In addition, the solution claims to double the site feasibility response rate against the industry average. It also helps to reduce the timeline and burden for sites and sponsors during the site assessment and selection process. Users will be able to access comprehensive details on site offerings, staff, and logistics through over 300 standardised fields. The software features a self-service or high-touch experience option, with wrap-around services, offering clinical development insights and site detection for supporting end-to-end trial start-up. WCG noted that the solution features real-time tracking, scoring, and analysis of responses, allowing for quick decision making. It claims to decrease redundancy, enhance partnerships, accelerate outcomes, decrease the site workload, and offer rapid turnaround times. The self-service ability of the solution provides CROs and sponsors with a tool to 'streamline' operations, minimise expenses, and enhance site relationships during the trial feasibility process. WCG CEO Sam Srivastava said: 'WCG ClinSphere Total Feasibility revolutionises the study start-up process. 'By integrating comprehensive data combined with user-friendly tools, we empower research teams with the insights they need to make informed decisions quickly. This innovation is central to our mission to improve lives by accelerating research, bringing life-saving treatments to patients sooner.' In May 2023, WCG introduced an integrated solution to meet the ICH E8 R1 needs and improve trial predictability. "WCG launches SaaS solution to optimise trial site selection" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
10-03-2025
- Business
- Yahoo
Clario Enters into Definitive Agreement to Acquire WCG's eCOA Business
Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and efficacy of new drugs by measuring how a clinical trial participant feels or functions. WCG's eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases. "WCG's eCOA business has a well-earned reputation for industry-leading expertise in neuroscience. Adding their scientific and operational capabilities to expand our neuroscience capabilities in imaging and digital physiology aligns with Clario's vision to transform lives by unlocking actionable evidence," said Chris Fikry, M.D., chief executive officer, Clario. "I am excited about the long-term positive impact this will have on customers and patients." "WCG's eCOA expertise and capabilities in subjective endpoints are a strategic and complementary fit with Clario's endpoint solutions. This transaction allows WCG to focus on being a trusted partner in connecting sponsors and CROs with sites to accelerate trials through trial design, study review, site activation, and participant recruitment and retention," said Sam Srivastava, chief executive officer, WCG. "With a legacy of supporting clinical trials over more than five decades across 130 countries, we remain well-positioned to accelerate clinical research through our AI-enabled data, technology, and expertise, paving the way to bring life-saving therapies to patients, faster." Customers of both companies can expect no immediate changes to existing contracts or relationships. "This complementary acquisition will augment our offerings by expanding our scientific expertise and service delivery capabilities," said Clario EVP and General Manager of eCOA, Terry Burke. "I am delighted that we will be positioned to further enable the success of our customers and ultimately have a greater impact on patients with unmet medical needs." The transaction is subject to regulatory approvals and other customary closing conditions. Until the acquisition closes, both organizations will continue to operate as independent entities. About Clario Clario is a leading provider of endpoint data solutions to the clinical trials industry, generating high-quality clinical evidence for life sciences companies. We offer comprehensive evidence-generation solutions that combine medical imaging, eCOA, precision motion, cardiac solutions and respiratory endpoints. For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have been deployed over 26,000 times to support clinical trials in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2012. Clario's shareholders are Astorg, Nordic Capital, Novo Holdings, and Cinven. For more information, go to or follow us on LinkedIn. About WCG WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit or follow us on LinkedIn or X @WCGClinical. Clario Media Contact:David Malleymedia@ WCG Media Contact:Carmin Gade, PhD484.351.9959cgade@ View original content to download multimedia: SOURCE Clario Sign in to access your portfolio
